Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices.

Cardiac electronic implantable device Defibrillator Défibrillateur French Society of Cardiology Imagerie par résonance magnétique ;Dispositif électronique cardiaque implantable Magnetic resonance imaging Pacemaker Société Française de Cardiologie Stimulateur cardiaque

Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Historique:
received: 21 01 2020
revised: 24 03 2020
accepted: 25 03 2020
pubmed: 1 6 2020
medline: 2 9 2020
entrez: 1 6 2020
Statut: ppublish

Résumé

Magnetic resonance imaging (MRI) has become the reference imaging technique for the management of a large number of diseases. The number of MRI examinations increases every year, simultaneously with the number of patients receiving a cardiac electronic implantable device (CEID). The presence of a CEID was considered an absolute contraindication for MRI for many years. The progressive replacement of conventional pacemakers and defibrillators by "magnetic resonance (MR)-conditional" CEIDs and recent data on the safety of MRI in patients with "MR-non-conditional" CEIDs have gradually increased the demand for MRI in patients with a CEID. However, some risks are associated with MRI in CEID carriers, even with MR-conditional devices, because these devices are not "MR safe". Specific programming of the device in "MR mode" and monitoring patients during MRI remain mandatory for all patients with a CEID. A standardized patient workflow based on an institutional protocol should be established in each institution performing such examinations. This joint position paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging describes the effect of and risks associated with MRI in CEID carriers. We propose recommendations for patient workflow and monitoring and CEID programming in MR-conditional, "MR-conditional non-guaranteed" and MR-non-conditional devices.

Identifiants

pubmed: 32473997
pii: S1875-2136(20)30106-6
doi: 10.1016/j.acvd.2020.03.015
pii:
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

473-484

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

Estelle Gandjbakhch (E)

Sorbonne University, Heart Institute, La Pitié-Salpêtrière University Hospital, AP-HP, 75013 Paris, France. Electronic address: estelle.gandjbakhch@aphp.fr.

Jean-Nicolas Dacher (JN)

Cardiac Imaging Unit, Department of Radiology, Rouen University Hospital, 76031 Rouen, France.

Jerome Taieb (J)

Department of Cardiology, Aix-en-Provence Hospital, 13100 Aix-en-Provence, France.

Michel Chauvin (M)

Department of Cardiology, University Hospital, 67000 Strasbourg, France.

Frederic Anselme (F)

Department of Cardiology, Rouen University Hospital, 76000 Rouen, France.

Axel Bartoli (A)

Department of Radiology, La Timone 2 University Hospital, Aix-Marseille University, CNRS, CRMBM, CEMEREM, 13005 Marseille, France.

Louis Boyer (L)

Department of Radiology, University Hospital Gabriel Montpied, 63000 Clermont-Ferrand, France.

Lucie Cassagnes (L)

Department of Radiology, University Hospital Gabriel Montpied, 63000 Clermont-Ferrand, France.

Hubert Cochet (H)

Department of Cardiovascular Imaging, Haut-Lévêque Cardiological Hospital, CHU de Bordeaux, IHU LIRYC, Université de Bordeaux-Inserm, 33600 Pessac, France.

Pascal Defaye (P)

Department of Cardiology, Grenoble University Hospital, 38700 La Tronche, France.

Jean-Claude Deharo (JC)

Department of Cardiology, La Timone University Hospital, 13005 Marseille, France.

Benjamin Dubourg (B)

Cardiac Imaging Unit, Department of Radiology, Rouen University Hospital, 76031 Rouen, France.

Laurent Fauchier (L)

Department of Cardiology, Tours University Hospital, 37000 Tours, France.

Daniel Gras (D)

Nouvelles Cliniques Nantaises, 44200 Nantes, France.

Didier Klug (D)

Department of Cardiology, Lille University Hospital, 59000 Lille, France.

Gabriel Laurent (G)

Department of Cardiology, Dijon University Hospital, 21000 Dijon, France.

Jacques Mansourati (J)

Department of Cardiology, Brest University Hospital, 29200 Bres, France.

Eloi Marijon (E)

Department of Cardiology, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.

Philippe Maury (P)

Department of Cardiology, Rangueil University Hospital, 31059 Toulouse; Unité Inserm U1048, 31432 Toulouse, France.

Olivier Piot (O)

Centre Cardiologique du Nord, 93200 Saint-Denis, France.

François Pontana (F)

Department of Cardiovascular Radiology, Institut Cœur-Poumon, Inserm UMR 1011, Lille University Hospital, 59000 Lille, France.

Frederic Sacher (F)

Department of Cardiology, Haut-Lévêque Cardiological Hospital, CHU de Bordeaux, IHU LIRYC, Université de Bordeaux-Inserm, 33600 Pessac, France.

Nicolas Sadoul (N)

Department of Cardiology, Nancy University Hospital, 54511 Vandoeuvre-lès-Nancy, France.

Alexis Jacquier (A)

Department of Radiology, La Timone 2 University Hospital, Aix-Marseille University, CNRS, CRMBM, CEMEREM, 13005 Marseille, France.

Serge Boveda (S)

Clinique Pasteur, 31076 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH